Atezolizumab, a monoclonal antibody developed by Roche that is currently in clinical trails, could be set to change the landscape of lung cancer treatment for physicians and patients. A pair of German investigators...
Atezolizumab, a monoclonal antibody developed by Roche that is currently in clinical trails, could be set to change the landscape of lung cancer treatment for physicians and patients. A pair of German investigators...
...